Literature DB >> 1905700

Alteration of physiological activity of activated macrophages through L-arginine metabolism.

M Takema1, K Inaba, K Okazaki, K Uno, K Tawara, S Muramatsu.   

Abstract

Our aim in this study was to define the effect of L-arginine on macrophages (M phi) in relation to the decay of tumoricidal activity of activated M phi. We found that the activated M phi retained their cytotoxicity when cultured in L-arginine-deficient medium but not in conventional medium. Such a decline of tumoricidal activity was associated with increase of glucose consumption and concomitant lactate production, resulting in M phi death. Addition of glucose to the culture medium of activated M phi appeared to cause only a slight delay of the decrease of tumoricidal activity and M phi death. These events were also coincident with a decrease of electron transport activity in mitochondria. Cytological observation by electron microscopy clearly showed the structural alteration or destruction of mitochondria, which preceded the changes of other physiological and functional activities. These results demonstrate that the L-arginine-dependent cytolytic activity against tumor target cells also impairs M phi functions and ultimately induces M phi death, which is primarily mediated by the inhibition of mitochondrial activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905700      PMCID: PMC5918479          DOI: 10.1111/j.1349-7006.1991.tb01884.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


macrophage(s) MEM depleted of L‐arginine lipopolysaccharide normal MEM thioglycollate broth lactate dehydrogenase
  30 in total

1.  Activated macrophages as cytotoxic effector cells. II. Requirement for local persistence of inducing antigen.

Authors:  J B Hibbs
Journal:  Transplantation       Date:  1975-01       Impact factor: 4.939

2.  Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMP.

Authors:  R M Schultz; N A Pavlidis; J N Stoychkov; M A Chirigos
Journal:  Cell Immunol       Date:  1979-01       Impact factor: 4.868

3.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway.

Authors:  J E Albina; C D Mills; W L Henry; M D Caldwell
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

5.  Nutrient utilization by peritoneal exudate cells.

Authors:  C C Stewart
Journal:  J Reticuloendothel Soc       Date:  1973-10

6.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

7.  The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms.

Authors:  J L Humes; S Burger; M Galavage; F A Kuehl; P D Wightman; M E Dahlgren; P Davies; R J Bonney
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

8.  Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.

Authors:  R Keller; R Keist; P H Van der Meide; P Groscurth; M Aguet; T P Leist
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

9.  Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.

Authors:  S M Taffet; S W Russell
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

10.  Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.

Authors:  R M Schultz; N A Pavlidis; W A Stylos; M A Chirigos
Journal:  Science       Date:  1978-10-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.